322 related articles for article (PubMed ID: 27256979)
1. Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment.
Czapiewski P; Kunc M; Haybaeck J
Oncotarget; 2016 Aug; 7(32):52584-52596. PubMed ID: 27256979
[TBL] [Abstract][Full Text] [Related]
2. Relationship of p53 gene alterations with tumor progression and recurrence in olfactory neuroblastoma.
Papadaki H; Kounelis S; Kapadia SB; Bakker A; Swalsky PA; Finkelstein SD
Am J Surg Pathol; 1996 Jun; 20(6):715-21. PubMed ID: 8651351
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Molecular Profiling of Olfactory Neuroblastoma Identifies Potentially Targetable
Lazo de la Vega L; McHugh JB; Cani AK; Kunder K; Walocko FM; Liu CJ; Hovelson DH; Robinson D; Chinnaiyan AM; Tomlins SA; Harms PW
Mol Cancer Res; 2017 Nov; 15(11):1551-1557. PubMed ID: 28775129
[TBL] [Abstract][Full Text] [Related]
4. Cytopathologic features of olfactory neuroblastoma.
Mahooti S; Wakely PE
Cancer; 2006 Apr; 108(2):86-92. PubMed ID: 16456848
[TBL] [Abstract][Full Text] [Related]
5. Of mice and men: olfactory neuroblastoma among animals and humans.
Lubojemska A; Borejko M; Czapiewski P; Dziadziuszko R; Biernat W
Vet Comp Oncol; 2016 Sep; 14(3):e70-82. PubMed ID: 25041470
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine Neoplasms of the Sinonasal Tract: Neuroendocrine Carcinomas and Olfactory Neuroblastoma.
Shah K; Perez-Ordóñez B
Head Neck Pathol; 2016 Mar; 10(1):85-94. PubMed ID: 26830400
[TBL] [Abstract][Full Text] [Related]
7. Olfactory Neuroblastoma with Divergent Differentiation: An Unusual Histologic Finding in a Rare Tumor.
Meyer C; Hamersley ERS; Manosalva RE; Torske K; McIntyre N; Mitchell A
Head Neck Pathol; 2017 Dec; 11(4):531-536. PubMed ID: 28168398
[TBL] [Abstract][Full Text] [Related]
8. Olfactory neuroblastoma (esthesioneuroblastoma) and esthesioneuroepithelioma: histologic and immunohistochemical study.
Taraszewska A; Czorniuk-Sliwa A; Dambska M
Folia Neuropathol; 1998; 36(2):81-6. PubMed ID: 9757618
[TBL] [Abstract][Full Text] [Related]
9. Molecular Evidence for Olfactory Neuroblastoma as a Tumor of Malignant Globose Basal Cells.
Zunitch MJ; Fisch AS; Lin B; Barrios-Camacho CM; Faquin WC; Tachie-Baffour Y; Louie JD; Jang W; Curry WT; Gray ST; Lin DT; Schwob JE; Holbrook EH
Mod Pathol; 2023 May; 36(5):100122. PubMed ID: 36841178
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathologic study of sinonasal teratocarcinosarcoma and its contrast with olfactory neuroblastoma].
Li X; Liu HG; Xie XJ; Han YD; Li M
Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):458-64. PubMed ID: 19035117
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and the molecular biomarkers of olfactory neuroblastoma.
Peng X; Liu Y; Peng X; Wang Z; Zhang Z; Qiu Y; Jin M; Wang R; Kong D
Pathol Res Pract; 2018 Aug; 214(8):1123-1129. PubMed ID: 29921494
[TBL] [Abstract][Full Text] [Related]
12. Mixed Olfactory Neuroblastoma and Adenocarcinoma with In Situ Neuroendocrine Hyperplasia.
Attwood JE; Jeyaretna DS; Sheerin F; Shah KA
Head Neck Pathol; 2020 Sep; 14(3):792-798. PubMed ID: 31388897
[TBL] [Abstract][Full Text] [Related]
13. The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: Refinements in diagnostic criteria and impact of multimodal treatments on survival.
Turri-Zanoni M; Maragliano R; Battaglia P; Giovannardi M; Antognoni P; Lombardi D; Morassi ML; Pasquini E; Tarchini P; Asioli S; Foschini MP; Sessa F; Nicolai P; Castelnuovo P; La Rosa S
Oral Oncol; 2017 Nov; 74():21-29. PubMed ID: 29103747
[TBL] [Abstract][Full Text] [Related]
14. Recurrent Olfactory Neuroblastoma Treated With Cetuximab and Sunitinib: A Case Report.
Wang L; Ding Y; Wei L; Zhao D; Wang R; Zhang Y; Gu X; Wang Z
Medicine (Baltimore); 2016 May; 95(18):e3536. PubMed ID: 27149458
[TBL] [Abstract][Full Text] [Related]
15. Activation of sonic hedgehog signaling pathway in olfactory neuroblastoma.
Mao L; Xia YP; Zhou YN; Dai RL; Yang X; Wang YJ; Duan SJ; Qiao X; Mei YW; Hu B
Oncology; 2009; 77(3-4):231-43. PubMed ID: 19738389
[TBL] [Abstract][Full Text] [Related]
16. Olfactory Neuroblastoma: Morphological Reappraisal and Molecular Insights with Quantum Leap in Clinical Perspectives.
Bell D; Brandea AI; Hanna EY
Curr Oncol Rep; 2023 Jan; 25(1):11-18. PubMed ID: 36449116
[TBL] [Abstract][Full Text] [Related]
17. Odorant receptor genes are expressed in olfactory neuroblastoma.
Gonzalez-Kristeller DC; Gutiyama LM; Campos AH; Soares FA; Brentani H; Malnic B
Genet Mol Res; 2013 Sep; 12(3):3479-87. PubMed ID: 24065686
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas.
Topcagic J; Feldman R; Ghazalpour A; Swensen J; Gatalica Z; Vranic S
PLoS One; 2018; 13(1):e0191244. PubMed ID: 29324814
[TBL] [Abstract][Full Text] [Related]
19. Expression of the human Achaete-scute 1 gene in olfactory neuroblastoma (esthesioneuroblastoma).
Carney ME; O'Reilly RC; Sholevar B; Buiakova OI; Lowry LD; Keane WM; Margolis FL; Rothstein JL
J Neurooncol; 1995 Oct; 26(1):35-43. PubMed ID: 8583243
[TBL] [Abstract][Full Text] [Related]
20. Proceedings of the 2023 North American Society of Head and Neck Pathology Companion Meeting, New Orleans, LA, March 12, 2023: Navigating New Developments in High Grade Sinonasal Neuroendocrine and Neuroectodermal Neoplasms.
Rooper LM
Head Neck Pathol; 2023 Jun; 17(2):299-312. PubMed ID: 37184733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]